Increased plasma IL-17, IL-31, and IL-33 levels in chronic spontaneous urticaria (Q47106942)

8 January 2018

title

Increased plasma IL-17, IL-31, and IL-33 levels in chronic spontaneous urticaria (English)

1 reference

8 January 2018

1 reference

Wei Lin

1

1 reference

8 January 2018

Qiongyan Zhou

2

1 reference

8 January 2018

Chunbo Liu

3

1 reference

8 January 2018

Mengxia Ying

4

1 reference

8 January 2018

Suling Xu

5

1 reference

8 January 2018

language of work or name

English

0 references

publication date

19 December 2017

1 reference

8 January 2018

published in

Scientific Reports

1 reference

8 January 2018

volume

7

1 reference

8 January 2018

page(s)

17797

1 reference

8 January 2018

issue

1

1 reference

8 January 2018

Creative Commons Attribution 4.0 International

copyright license

start time

1 December 2017

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1038/s41598-017-18187-z

0 references

cites work

Clinical observation on the therapeutic effect of desloratadine citrate disodium in the treatment of chronic urticaria and changes in IL4, IL18, IL23 and IL-33 levels before and after treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5736548

The relationship between circulating concentrations of interleukin 17 and C reactive protein in chronic spontaneous urticaria

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5736548

Anti-Interleukin-31 Receptor A Antibody for Atopic Dermatitis.

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5736548

Elevations in T-helper-2-initiating cytokines (interleukin-33, interleukin-25 and thymic stromal lymphopoietin) in lesional skin from chronic spontaneous ('idiopathic') urticaria.

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5736548

The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5736548

Interleukin-31: a novel diagnostic marker of allergic diseases.

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5736548

IL-33 induces a hyporesponsive phenotype in human and mouse mast cells.

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5736548

IgE mediated autoallergy against thyroid peroxidase--a novel pathomechanism of chronic spontaneous urticaria?

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5736548

Interleukin-33 biology with potential insights into human diseases

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5736548

IL-33 is produced by mast cells and regulates IgE-dependent inflammation

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5736548

Potential role of Th17 cells in the pathogenesis of inflammatory bowel disease

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5736548

IL-33 synergizes with IgE-dependent and IgE-independent agents to promote mast cell and basophil activation

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5736548

Structures and biological functions of IL-31 and IL-31 receptors

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5736548

Pathophysiology of urticaria.

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5736548

IL-31: a new link between T cells and pruritus in atopic skin inflammation

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5736548

IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5736548

T1/ST2--an IL-1 receptor-like modulator of immune responses.

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5736548

Cytokines and autoimmunity

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5736548

T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5736548

Different expression patterns of plasma Th1-, Th2-, Th17- and Th22-related cytokines correlate with serum autoreactivity and allergen sensitivity in chronic spontaneous urticaria.

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5736548

IL-33/ST2 axis controls Th2/IL-31 and Th17 immune response in allergic airway diseases.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5736548

Successful omalizumab treatment in chronic spontaneous urticaria is associated with lowering of serum IL-31 levels.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5736548

Increased serum levels of interleukin 33 in patients with atopic dermatitis.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5736548

Expression of IL-33 in the epidermis: The mechanism of induction by IL-17.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5736548

Serum concentration of IL-17, IL-23 and TNF-α among patients with chronic spontaneous urticaria: association with disease activity and autologous serum skin test

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5736548

Statin effects on regulatory and proinflammatory factors in chronic idiopathic urticaria.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5736548

Complete overlap of interleukin-31 receptor A and oncostatin M receptor beta in the adult dorsal root ganglia with distinct developmental expression patterns.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5736548

Chronic idiopathic urticaria: infiltrating cells and related cytokines in autologous serum-induced wheals

15 August 2018

1 reference

https://api.crossref.org/works/10.1038%2FS41598-017-18187-Z

7 January 2021

A serological mediator in chronic idiopathic urticaria--a clinical, immunological and histological evaluation

1 reference

https://api.crossref.org/works/10.1038%2FS41598-017-18187-Z

7 January 2021

High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism

1 reference

https://api.crossref.org/works/10.1038%2FS41598-017-18187-Z

7 January 2021

Correlation of IL-31 serum levels with severity of atopic dermatitis

1 reference

https://api.crossref.org/works/10.1038%2FS41598-017-18187-Z

7 January 2021

Interleukin (IL)-31 induces pro-inflammatory cytokines in human monocytes and macrophages following stimulation with staphylococcal exotoxins

1 reference

https://api.crossref.org/works/10.1038%2FS41598-017-18187-Z

7 January 2021

IL-33 and ST2 in Atopic Dermatitis: Expression Profiles and Modulation by Triggering Factors

1 reference

https://api.crossref.org/works/10.1038%2FS41598-017-18187-Z

7 January 2021

Increased circulating pro-inflammatory cytokines and imbalanced regulatory T-cell cytokines production in chronic idiopathic urticaria

1 reference

https://api.crossref.org/works/10.1038%2FS41598-017-18187-Z

7 January 2021

Anti-interleukin-31-antibodies ameliorate scratching behaviour in NC/Nga mice: a model of atopic dermatitis

1 reference

https://api.crossref.org/works/10.1038%2FS41598-017-18187-Z

7 January 2021

Increased levels of serum IL-31 in chronic spontaneous urticaria

1 reference

https://api.crossref.org/works/10.1038%2FS41598-017-18187-Z

7 January 2021

Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cells

1 reference

https://api.crossref.org/works/10.1038%2FS41598-017-18187-Z

7 January 2021

Different serum cytokine levels in chronic vs. acute Anisakis simplex sensitization-associated urticaria

1 reference

https://api.crossref.org/works/10.1038%2FS41598-017-18187-Z

7 January 2021

Free IL-18 and IL-33 cytokines in chronic spontaneous urticaria

1 reference

https://api.crossref.org/works/10.1038%2FS41598-017-18187-Z

7 January 2021

TSLP, IL-31, IL-33 and sST2 are new biomarkers in endophenotypic profiling of adult and childhood atopic dermatitis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29259273

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1038/S41598-017-18187-Z

1 reference

8 January 2018

PMCID

5736548

1 reference

8 January 2018

PubMed ID

29259273

1 reference

8 January 2018